Public Health

Debate between Bernard Jenkin and Matt Hancock

Wednesday 6th January 2021 Commons Chamber

[Matt Hancock]

Of course we are considering who, once we have vaccinated those who are clinically vulnerable, should be the next priority for vaccination. Teachers, of course, have a very strong case, as have those who work in nurseries. Many colleagues on both sides of the House have made that point, and we will consider it.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

Just to pick up one point, the Secretary of State cites the certain knowledge that there is a way out. The whole point of the intervention by the right hon. Member for Warley (John Spellar) is that there is uncertainty. What contingency plans are there if a mutation proves resistant to either of the vaccines and we have to be in these measures for longer? In particular, will the Secretary of State consider the fact that we have barely drawn on the numerous people in the armed forces to create extra NHS capacity? We could do so much more of that if necessary. Is that part of the plan?

[Matt Hancock]

Yes, it is very much part of the plan; it is happening right now. On mutations and the link to the vaccine, as with flu, where mutations mean we have to change the vaccine each year, any vaccine might have to be updated in the future, but that is not our understanding of the situation now. Of course that is being double-checked and tested, both with the scientists at Porton Down and, as we roll out the vaccine in areas where there is a high degree of the new variant, and by the pharmacological surveillance of those who have been vaccinated, which will allow us to see for real the impact of the vaccine on the new variant. The goal, as my right hon. Friend the Prime Minister said, is that by the middle of next month we plan to have offered the first dose to everyone in the top four priority groups, and they currently account for four out of five covid fatalities. I am not sure that this point has fully been addressed, but the strong correlation between age and fatality from covid means we will be able to vaccinate those who account for four out of every five fatalities within the top four cohorts. It does then take two to three weeks from the first dose to reach immunity, but the vaccine is therefore the way out of this pandemic and the way to a better year ahead.

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Wednesday 30th December 2020 Commons Chamber

[Matt Hancock]

I am not sure that the hon. Lady was listening when I said in my statement that the NHS is under very significant pressure. Of course we are working hard to ensure that that pressure is alleviated as much as possible. Over the summer, we built significant extra capacity into the critical care facilities of the NHS, including across London. The Nightingale hospitals are there, as she puts it, as an insurance policy—as back-up. The London Nightingale hospital is there on standby as back-up. I have seen some stories circulating saying that it has been decommissioned. Those stories are wrong. It is better for people if they are treated inside a hospital, but the Nightingales are there for extra support should it be needed. It will require changes to the working patterns of staff if we do need to have patients in the Nightingales once more, but it is crucial, in my view, that we have those Nightingales there ready in case we need them.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

I can confirm to my right hon. Friend that Essex has declared a major incident. It is also, at this very moment, submitting a MACA—military aid to the civil authorities—request to assist with the construction of community hospitals for additional hospital capacity, supported and partly staffed by the armed forces. It would also like armed forces help with the roll-out of the vaccine to accelerate that in Essex and to assist with testing in schools. Will he look into the German BioNTech test as an alternative to the lateral flow test, as it is as reliable as the PCR—polymerase chain reaction test—and turns around in one hour?

[Matt Hancock]

I will absolutely look into, and get back to my hon. Friend about, the BioNTech test. Of course, BioNTech is an absolutely fabulous pharmaceutical company, as the whole House knows. What he says about the pressures in Essex is very significant, and it is important. Of course, I will look favourably on any request for military assistance, working closely with my right hon. Friend the Defence Secretary, who has been incredibly supportive, as have the whole armed forces, during this whole year. They have done so much. They are already involved in the roll-out of testing, as my hon. Friend knows, and we draw on the ingenuity, reserve and sheer manpower of the armed forces when we need them. I am very grateful for my hon. Friend’s support for the work that we all need to do in Essex to support the NHS there and to try to get the number of cases down.

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Thursday 17th December 2020 Commons Chamber

[Matt Hancock]

This has been an incredibly difficult year for so many people and so many families. The fixed numerical limits place a particular burden on very large families. We have taken, I think, a balanced and right approach, but while I understand the urge for caution—of course I understand that, from my NHS colleagues and others—I also understand that people want to see their children and their loved ones. Christmas is an important time of year, and we have to find a balance.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

I join my right hon. Friend in wishing NHS staff and everyone in this crisis a happy Christmas. Will he join me in wishing Essex County Council and local authorities in Essex a happy Christmas for what they have contributed to the test, track and trace operation since NHS Test and Trace started to share data much more quickly with local authorities? I can report to him that most districts have started door-knocking to follow up the contacts of cases, and the complete case contact rates are now around 87% and 90% respectively. Will he join me in congratulating the local authorities of Essex on this tremendous effort?

[Matt Hancock]

My hon. Friend is absolutely right, and I am grinning because I think this is the first time in the dozens and dozens of statements I have made this year when the hon. Member for Leicester South (Jonathan Ashworth) has not mentioned track and trace. I will tell you why, Madam Deputy Speaker: the latest statistics show that where communications were available, 96.6% of people were reached and told to self-isolate. That is because of the huge improvements in contact tracing and testing that have been delivered this year—[Hon. Members: “By local authorities.”] Including, of course, by local authority partners, but also by the brilliant national NHS Test and Trace system, which we should all congratulate. Getting those contact rates—[Interruption.]

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Monday 14th December 2020 Commons Chamber

[Matt Hancock]

We are trying to support the economy as much as possible throughout all these difficult decisions. The extraordinary levels of financial support are a part of that, including the furlough scheme, which has now been extended to the end of March. I, of course, talk to my right hon. Friend the Work and Pensions Secretary regularly to make sure we take the action that is necessary in a way that supports people as much as possible.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

I thank my right hon. Friend for his statement, albeit that it contains a lot of very grim news about the virus itself and its effect on many areas. It will be greeted with considerable relief in Harwich, Clacton, Colchester and Uttlesford, where the virus rates are much lower and we will stay in tier 2. Is the message now not that we stay in tier 2 or go down a tier much more by our own efforts—by the efforts of local authorities, with the support of NHS Test and Trace—to make sure we support those who have to isolate and track down and trace those who are spreading the virus? By doing that, and by compliance and forbearance, we can reduce the spread of the virus and help to defeat it so we can get down the tiers.

[Matt Hancock]

Yes. My hon. Friend is absolutely right. Trying to keep the virus under control is in the hands of local authorities and local communities. I would say to everybody in Harwich, and people across the south-east and east of England who have not gone into tier 3 today, that we all still need to work together, be vigilant and effectively do everything we can to stop the spread of the disease, because so many people are asymptomatic—about a third—and never have any symptoms but can nevertheless spread the disease. I am very grateful to my hon. Friend for the work he has done in giving me ideas to support colleagues to help in that effort. The links between the national system and local authorities are getting stronger all the time, and I want colleagues to be able to play our part—especially as, through our campaigning, we know our communities well—by getting into communities to spread the message that if we all stick by the rules and we get the testing and contact tracing in, we will be able to keep this under control.

Coronavirus Vaccine

Debate between Bernard Jenkin and Matt Hancock

Wednesday 2nd December 2020 Commons Chamber

[Matt Hancock]

The hon. Gentleman has worked supportively and constructively with the Government throughout this pandemic. I pay tribute to the approach that he has taken, and that he took again today.

I stand with the hon. Gentleman in saying that vaccinations save lives. If we can encourage anybody who might be hesitant to take a vaccine by appearing together to be vaccinated together, of course I would be happy to do that. I recommend that we have a professional vaccinate us, of course—I do not think that he would trust me to do it.

The hon. Gentleman asked for a public information campaign, and there will of course be one. He asked about health inequalities, which are a very important consideration. The best thing to support tackling health inequalities is the fact that we have a vaccine, but we absolutely need to reach all parts and all communities across the whole country.

The hon. Gentleman asked how many will be vaccinated by January. While today brings more certainty, it does not end all uncertainties. We have 800,000 doses that have now passed the batch testing, but the total number to be manufactured over this timeframe is not yet known, because it is all dependent on the manufacturing process, which is itself complicated. After all, this is not a chemical but a biological product, so I cannot answer that question—that is as yet unknowable.

The hon. Gentleman asked when the PCNs and the centres will open. The answer is very soon. We have 50 hospital hubs ready to go from next week. The PCNs are also being stood up, and the centres outside hospitals. They are all coming very soon.

The hon. Gentleman then asked when we will get to lift restrictions. Of course, I understand why not only he but almost everybody in the country wants to know the answer to this question: how many people do we have to vaccinate before we can start lifting the restrictions? The answer to that is that, while we know that the vaccine protects an individual with a 95% efficacy, we do not know the impact of the vaccine on reducing transmission, because of the problem of asymptomatic transmission, which has so bedevilled our response to this virus and made it so hard to tackle.

We do not know the answer to that question, but what we will do is to follow the same five indicators that we were discussing at length yesterday, which are the indicators of the spread of the disease. We will look at the cases, the hospitalisations and of course the number of people who die with covid, and we will hope very much that, as we vaccinate more and more vulnerable people, we will see those rates come down and therefore be able to lift the restrictions. We will have to see how the vaccination programme impacts directly on the epidemic, and then move as swiftly as we safely can to lift the restrictions, which we all want to see gone.

The hon. Gentleman asked about community testing being licensed from door to door. I have not heard about that problem—I will ensure that I get back not only to him, but to those who raised it with him, if he will work with me. I am a bit surprised to hear that. Administering the lateral flow test currently requires a professional, although we hope to move on from that, but as far as I know it can take place in any setting, hence my surprise. However, as the comment was made by a public health professional, I shall dig into it further.

Finally, the hon. Gentleman talked about the testing prospectus we launched on Monday. We hope to be able to use testing to do more things that we would not be able to do without testing. In a way, visits to care homes are an example of that, as something we can now safely recommend that we could not recommend before; so too is testing to release from quarantine people coming into this country. If there are further examples of that sort of enablement of normal life through the use of testing that can be safely done and can be approved by a director of public health and by the chief medical officer and his team, we are enthusiastic about working with local areas to deliver it on the ground.

There are lots of ideas out there, and I urge people to be creative about how we can we can use testing to enable some of the things we love to get going again in a way that keeps people safe. That is what that part of the testing prospectus was about. I am very enthusiastic about it and look forward to working with directors of public health and with colleagues in this House. Yesterday, the Prime Minister said that with the roll-out of mass testing and the availability of these tests, we all, as leaders in our local communities, have a role in promoting mass testing. I am sure that there are communities across the country represented in this House that can benefit from the roll-out.

Looking around the Chamber right now, I see many people who have already approached me—not just from Lancashire. I look forward to working with colleagues in all parts of the House to promote this public health message, along with all the other important public health messages we have to promote, not least that if the NHS phones you up or sends you a letter saying that there is a vaccination slot open to you, just say yes.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

I congratulate my right hon. Friend on this moment and the Government on the news about the Pfizer vaccine, but please can we continue to have increased honesty about what we still do not know? We do not know how long the immunity will last, we do not even know whether people who have been vaccinated can still transmit the disease, and of course we do not know whether tier 2 restrictions will succeed in bringing the R rate down. Until we can answer those questions, we will continue to need maximum effort behind contact tracing and isolation of virus spreaders.

Councils including Essex County Council need daily access to all the positive cases recorded by NHS Test and Trace immediately and without delay, so that they can make their own operations effective, so why are they having to wait 48 to 72 hours before they get the data? Also, what are the Government going to do to engage districts and their community volunteer hubs to help to persuade people to support those who must still isolate even if they have been vaccinated?

[Matt Hancock]

Dealing with the pandemic has been a case of dealing with uncertainty in large degree. Today we have more certainty because we know this vaccine is safe and effective, but just as I said to the hon. Member for Leicester South (Jonathan Ashworth) that we do not know the effect of the vaccine on transmission, so, as my hon. Friend says, we do not know the longevity of its effectiveness.

My hon. Friend is right about another part of public health advice that all of us as local representatives can play a part in promoting: that is, engagement with contact tracing. I will write to him about access to daily data in Essex. Of course we have to wait until the test result comes in, which can sometimes lead to delay, even though the results of the majority of tests done in person now come back within 24 hours, but I agree with him in principle, so let us make it a reality in practice.

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Tuesday 10th November 2020 Commons Chamber

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

My right hon. Friend’s strategy is, as he keeps reporting to the House, to “suppress the virus” until a vaccine can be deployed, but this is still beset by so many uncertainties. Who would have thought that mink in Denmark could throw a spanner into this situation? Is the tracing capability and the ability to get people to isolate not absolutely crucial? Who should we hold accountable for whether that is operationally effective as we come out of lockdown? I say that because this is the only time we have got to make this work, otherwise we will be in another lockdown.

[Matt Hancock]

Of course it is important that we continue to build and strengthen the contact tracing system, as we are doing. My hon. Friend mentions the uncertainties, and the issue of the virus that has spread back from mink to humans is one example of that. Of course managing a pandemic is beset by uncertainty. We still have uncertainty, for instance, over whether even the Pfizer vaccine will pass the safety hurdles that we very much hope it will in the coming weeks, but managing through that uncertainty is a critical part of getting this right.

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Programme motion
Monday 19th October 2020 Commons Chamber

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

Most of the MPs in Essex have reluctantly felt the need to support the tier 2 measures that are now being applied, but we are very concerned about the effect of this on the hospitality sector, in particular. Is it not very important that we align the economic interests of our constituents with the public health interests instead of polarising the debate such that one is either in favour of the economy or in favour of controlling the virus? May I also emphasise that one of the reasons why public confidence in the Government’s strategy is somewhat in decline is that we have yet to see the transformation of the leadership of test and trace, which I have discussed with the Secretary of State many times?

[Matt Hancock]

Where I agree with my hon. Friend is that there is no trade-off between health and economic measures, because if the virus gets out of hand, then we will end up with a worse economic hit as well. I know he agrees with that because we have discussed it many times. He, like other Essex MPs, may not like the fact that we have to collectively put in place these measures in Essex, but it is the right course of action.

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Monday 5th October 2020 Commons Chamber

[Matt Hancock]

Yes. The hon. Member makes a really important point. This is why I resist the temptation to set a simplistic threshold above which a certain level of action is taken. That is because there might be an incident—I mentioned that there might be such an incident in a workplace, for instance; there might also be one in a halls of residence—where we get a very high number of cases, but if it is confined and not in the wider community we would not want to take action to restrict the social activity of the wider community. That has to be taken into account, along with the data on the number of cases and the positivity, because the number of tests that you put in affects that as well. We take all these things into account in asking both when an area needs to have more restrictions applied and when we can take an area out of restrictions, which of course is so important for everybody living there.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

Nobody can possibly doubt my right hon. Friend’s utter commitment to doing his very best in these circumstances, or indeed the good will and hard work of his officials, but this is another incident that further undermines public confidence in the delivery of the Government’s covid response, and it is another example of where logistics and planning have let us down. Why cannot the Government learn from previous successes with the Nightingale hospitals and personal protective equipment? The military were brought in much more overtly to deal with the logistics, planning and delivery of those programmes, and they should be on test and trace as well.

[Matt Hancock]

Of course they are involved, but this specific issue was in a PHE legacy computer system that we had already identified needed replacing; I had already commissioned the replacement of it and that replacement is currently being built. We knew that this was a system that needed replacing. That work is under way, at the same time as the remedial action to sort the problem more immediately.

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Monday 21st September 2020 Commons Chamber

[Matt Hancock]

I am very happy to work with the hon. Gentleman and others to make sure people get the fair treatment they deserve.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

At a time when we do not yet have the world-beating track and trace system or enough tests because of logistical problems, why are the Government excluding senior military commanders from key decision making and preventing them from bringing to bear their logistical capabilities?

[Matt Hancock]

On the contrary, the military’s support has been absolutely brilliant in expanding the testing system—test and trace—and it is engaged in the development of our vaccine roll-out plans. The work that senior military personnel have done is absolutely first rate.

Covid-19

Debate between Bernard Jenkin and Matt Hancock

Tuesday 1st September 2020 Commons Chamber

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

I thank the Secretary of State for the written ministerial statement he published after my last question to him in July. May I ask a bit more about the National Institute for Health Protection? Who was consulted before the decision was made? What is the legal basis for its present operation? Does it require legislation? What kind of public body is it intended to be: a non-ministerial department, an executive agency or a part of the Department of Health and Social Care? How will it be funded? When will there be a proper White Paper or Green Paper on the subject? Will the political appointee put in as interim head be replaced by a properly appointed public appointments-approved person? I could go on—there are plenty of unanswered questions.

[Matt Hancock]

I counted eight questions. Let me try to answer them. The National Institute for Health Protection does not require a legal basis; these PHE duties were not done on a legal basis. It will take on some UK-wide responsibilities, but also have responsibilities for England only. It is funded from the Department of Health and Social Care. It will be an executive agency of the Department. There is a global search under way for long-term, permanent leadership. As I said in response to the previous question, it will bring together the leadership of several different parts of the response. It was imperative, as far as I could see, to try to make sure we have that single unified leadership for the next stage of our response to the crisis. I pay tribute to the work of Public Health England. It has done an enormous amount, especially through its scientific work, which has truly been among the best in the world and has helped us to respond as well as we possibly could. I think that the new National Institute for Health Protection, established on the basis that I have set out, will make sure that we are constantly learning to have the best response, in terms of both the science and the scale, and to deliver for this country.

Covid-19 Update

Debate between Bernard Jenkin and Matt Hancock

Thursday 16th July 2020 Commons Chamber

[Matt Hancock]

Absolutely. Our approach is that the vaccines developed in the UK—supported by UK Government and, ultimately, UK taxpayers’ money—are of course there, should they come off, to provide protection to the UK population, but so too to the population around the world. We are using our official development assistance money to help ensure that there is broad global access, should they work. On the question about cyber-security and potential hacking, the hon. Member will understand why I cannot go into the full details, but I can reassure him that the National Cyber Security Centre is taking this very seriously.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

May I return to the question of public confidence? I thank my right hon. Friend for the tireless way that he submits himself to scrutiny by parliamentarians and the press, but will he accept that the public do want to understand more clearly what mistakes were made and what lessons have been learned? Can I perhaps invite him at least to table a written ministerial statement, before the rising of the House next week, that sets out the key lessons learned and how they are being implemented as we go into the autumn, which could be another very testing time for our country?

[Matt Hancock]

I am very happy to do that—I would not deny the Chair of the Liaison Committee his wishes on that—and I am very much looking forward to appearing before the Science and Technology Committee next week to answer any questions it might have.

Covid-19

Debate between Bernard Jenkin and Matt Hancock

Monday 16th March 2020 Commons Chamber

[Matt Hancock]

My hon. Friend the Economic Secretary to the Treasury tells me that undoubtedly the devolved nations will very rapidly get the information they need. After all, this is a UK-wide effort.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

Will my right hon. Friend join me in thanking the thousands of local community groups that are already mobilising in order to deal with what may be a very serious situation in their communities, involving looking after vulnerable people and even nursing the sick? Will he, with the Prime Minister and others, make sure that we mobilise these people and empower them to take decisions without having to wait for instructions?

NHS Funding Bill

Debate between Bernard Jenkin and Matt Hancock

2nd reading & 2nd reading: House of Commons
Monday 27th January 2020 Commons Chamber

[Matt Hancock]

We absolutely will be looking at doing that where we can. Unfortunately, that is difficult to do, because, over time, and especially during the time that the hon. Member for Leicester South was in the Treasury, the legals on these PFI deals got tighter and tighter. There are 106 PFI deals in hospitals and we are going through them. We will work towards making them work better for patients, and if that means coming out of them completely, I will be thrilled.

[Sir Bernard Jenkin (Harwich and North Essex) (Con)]

My right hon. Friend might know that I am a vice-president of Combat Stress, the charity for the mental welfare of our armed servicemen and veterans. Until recently it had a very tiny contract compared to the vast sums he has just announced—£3.1 million a year—and was treating some 250 patients a year with PTSD and other mental illnesses related to combat stress. Combat Stress is now having to discontinue taking referrals because the contract has come to an end. What prospect is there that there will be a new contract as soon as possible so Combat Stress can carry on its brilliant work?

[Matt Hancock]

I am very glad that my hon. Friend has raised this matter, because I was concerned to read the reports in the newspapers and have had a briefing this morning. There is work on a new contract to replace the old one, and I very much hope that that is settled and agreed as soon as possible.